[1] Cheung YM, Joham A, Marks S, et al. The obesity paradox: an endocrine perspective[J]. Intern Med J, 2017,47:727-733. [2] Kim WG, Lin JR, Blomain ES, et al. Anti-obesity pharmacotherapy: new drugs and emerging yargets[J]. Clin Pharmacol Ther, 2014,95:53-66. [3] Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential[J]. Nat Med, 2013,19:1252-1263. [4] Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults[J]. N Engl J Med, 2009,360:1518-1525. [5] van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-activated brown adipose tissue in healthy men[J]. N Engl J Med, 2009,360:1500-1508. [6] Min SY, Kady J, Nam M, et al. Human ‘brite/beige’ adipocytes develop from capillary networks, and their implantation improves metabolic homeostasis in mice[J]. Nat Med, 2016, 22: 312-318. [7] Niswender CM, Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease[J]. Annu Rev Pharmacol Toxicol, 2010,50:295-322. [8] Bradbury MJ, Campbell U, Giracello D, et al. Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice[J]. J Pharmacol Exp Ther, 2005,313:395-402. [9] Julio-Pieper M, Flor PJ, Dinan TG, et al. Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues[J]. Pharmacol Rev, 2011,63:35-58. [10] Shin S, Kwon O, Kang JI, et al. mGluR5 in the nucleus accumbens is critical for promoting resilience to chronic stress[J]. Nat Neurosci, 2015,18:1017-1024. [11] Tchernof A, Després JP. Pathophysiology of human visc-eral obesity: an update[J]. Physiol Rev, 2013,93: 359-404. |